Learn To Invest
Stocks Special Reports LICs Credit Funds ETFs Tools SMSFs
Video Archive Article Archive
News Stocks Special Reports Funds ETFs Features SMSFs Learn


Top 10 articles of last week

Lex Hall  |  14 Jan 2019Text size  Decrease  Increase  |  
Email to Friend

Our look at six downgraded global stocks worth considering led this week's coverage, alongside a $105bn cancer drug mega-merger, and why you should be sceptical about the 'January effect' and other myths.  

6 downgraded global stocks worth considering

Just because a company has been downgraded by Morningstar doesn't mean investors should sprint for the exits, writes Susan Dziubinski. 

2 drugmakers agree to $105bn mega-merger

Bristol-Myers Squibb Co says it will buy Celgene Corp for about $US74 billion ($105bn), combining two of the world's largest cancer drug businesses in the biggest pharmaceutical deal ever. 

Beware the January effect and other investing myths

At this time of year, you’ll hear a slew of common investing myths, like the 'January effect'. Learn why you should be sceptical about seasonal market trends. 

Banks brace for more Hayne pain this year

Commissioner Kenneth Hayne will on 1 February hand down his final recommendations from the financial services royal commission. 

Tax tips: guide to shareholding and trading as an investor

If you dabble regularly in share investment, the question might arise as to whether you have moved beyond being a passive investor in shares to someone who actively trades shares. 

For emerging markets tech is the new manufacturing 

Technologies like mobile banking, robotics, electric cars and online retailing allow EMs to accelerate growth.  

2 undervalued narrow moat ASX stocks

Investing Compass
Listen to Morningstar Australia's Investing Compass podcast
Take a deep dive into investing concepts, with practical explanations to help you invest confidently.
Investing Compass

Financial powerhouse Macquarie Group and infant formula brand A2 Milk marked a stellar 2018 by changing key personnel and bolstering their competitive advantage. 

Emerging Asia and US equities appeal in 2019, says BlackRock

Global asset managers are looking to US equities and emerging markets to offer value in the new year despite ongoing geopolitical ructions. 

Schlumberger, Wells Fargo crack global best ideas list

Oilfield services giant Schlumberger has joined integrated utility Entergy Corp and financial powerhouse Wells Fargo & Co in Morningstar's global equity best ideas list. 

3 top-rated ETFs for your portfolio

iShares, Magellan and Vanguard offer ETF options that carry enviable ratings and offer access to lucrative markets and a buffer against market downturns. 


is senior editor for Morningstar Australia

© 2022 Morningstar, Inc. All rights reserved. Neither Morningstar, its affiliates, nor the content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. This information is to be used for personal, non-commercial purposes only. No reproduction is permitted without the prior written consent of Morningstar. Any general advice or 'regulated financial advice' under New Zealand law has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892), or its Authorised Representatives, and/or Morningstar Research Ltd, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. For more information, refer to our Financial Services Guide (AU) and Financial Advice Provider Disclosure Statement (NZ). Our publications, ratings and products should be viewed as an additional investment resource, not as your sole source of information. Morningstar’s full research reports are the source of any Morningstar Ratings and are available from Morningstar or your adviser. Past performance does not necessarily indicate a financial product's future performance. To obtain advice tailored to your situation, contact a licensed financial adviser. Some material is copyright and published under licence from ASX Operations Pty Ltd ACN 004 523 782. The article is current as at date of publication.

Email To Friend